BAC
BMY icon

Boys Arnold & Co’s Bristol-Myers Squibb BMY Stock Holding History

Boys Arnold & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-34,554
Closed -$1.93M – 28
2020
Q1 		$1.93M Sell
34,554
-4,549
-12% -$278K 0.34% 72
2019
Q4 		$2.51M Buy
39,103
+11,200
+40% +$641K 0.34% 71
2019
Q3 		$1.4M Buy
27,903
+14,879
+114% +$699K 0.21% 104
2019
Q2 		$591K Buy
13,024
+879
+7% +$40.9K 0.09% 182
2019
Q1 		$579K Buy
12,145
+428
+4% +$21.3K 0.09% 182
2018
Q4 		$597K Sell
11,717
-30
-0.3% -$1.61K 0.1% 171
2018
Q3 		$729K Buy
11,747
+836
+8% +$49.6K 0.1% 168
2018
Q2 		$604K Buy
10,911
+57
+0.5% +$3.08K 0.09% 185
2018
Q1 		$555K Sell
10,854
-199
-2% -$12.8K 0.08% 196
2017
Q4 		$677K Buy
11,053
+1
+0% +$63 0.1% 177
2017
Q3 		$704K Buy
11,052
+3
+0% +$175 0.11% 169
2017
Q2 		$616K Sell
11,049
-999
-8% -$54.4K 0.08% 180
2017
Q1 		$655K Sell
12,048
-209
-2% -$11.5K 0.1% 170
2016
Q4 		$716K Buy
12,257
+666
+6% +$36.4K 0.12% 157
2016
Q3 		$625K Buy
11,591
+417
+4% +$26.8K 0.11% 163
2016
Q2 		$822K Buy
11,174
+6,686
+149% +$472K 0.14% 140
2016
Q1 		$287K Sell
4,488
-17,416
-80% -$1.1M 0.11% 129
2015
Q4 		$1.51M Buy
21,904
+10,953
+100% +$724K 0.16% 124
2015
Q3 		$648K Hold
10,951
– – 0.14% 142
2015
Q2 		$729K Buy
10,951
+1
+0% +$66 0.14% 139
2015
Q1 		$706K Buy
10,950
+51
+0.5% +$3.19K 0.13% 139
2014
Q4 		$643K Sell
10,899
-600
-5% -$33.8K 0.12% 136
2014
Q3 		$589K Sell
11,499
-2,267
-16% -$113K 0.12% 140
2014
Q2 		$668K Sell
13,766
-70
-0.5% -$3.45K 0.12% 142
2014
Q1 		$719K Sell
13,836
-160
-1% -$8.51K 0.13% 134
2013
Q4 		$744K Buy
13,996
+625
+5% +$31.8K 0.14% 121
2013
Q3 		$619K Hold
13,371
– – 0.13% 125
2013
Q2 		$598K Buy
+13,371
New +$580K 0.13% 120

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Boys Arnold & Co's BMY Position: Q2 2020 in Review

Boys Arnold & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 34,554 shares — an estimated $1.93M sold.

Boys Arnold & Co first reported a position in BMY in Q2 2013 and held it in 28 quarters. The position peaked at $2.51M in Q4 2019. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Boys Arnold & Co reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Boys Arnold & Co sold 34,554 Bristol-Myers Squibb shares in Q2 2020, an estimated $1.93M.
  • Boys Arnold & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 28 quarters.
  • Boys Arnold & Co's Bristol-Myers Squibb position peaked at $2.51M in Q4 2019.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Boys Arnold & Co's 13F filing for Q2 2020.